| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5476875 | BAUSCH | Catechol derivatives |
Dec, 2012
(11 years ago) | |
Tasmar is owned by Bausch.
Tasmar contains Tolcapone.
Tasmar has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Tasmar are:
- US5476875
Tasmar was authorised for market use on 29 January, 1998.
Tasmar is available in tablet;oral dosage forms.
Tasmar can be used as treatment of parkinson's disease.
The generics of Tasmar are possible to be released after 19 December, 2012.
Drugs and Companies using TOLCAPONE ingredient
Market Authorisation Date: 29 January, 1998
Treatment: Treatment of parkinson's disease
Dosage: TABLET;ORAL
More Information on Dosage
TASMAR family patents
